Posts Tagged: "Senate Banking Committee"

This Week in Washington: Digitized Payment Systems, Operation Warp Speed and Changing American Tech

This week in our nation’s capital, the Senate Banking Committee holds a hearing on introducing decentralized ledger technologies into government payment systems while the Senate Labor Subcommittee looks at Operation Warp Speed’s progress on developing a COVID-19 vaccine. Over in the House of Representatives, the House Rules Committee will look at amendments to the INVEST in America Act, a major transportation infrastructure bill which earmarks federal funding for mobility innovation programs. Elsewhere, New America looks at the impact that the year 2020 will have on the world of big tech while the Center for Strategic & International Studies discusses Main Street innovation in the defense sector with the company president of General Atomics, maker of the MQ-9 Reaper.

Capitol Hill Roundup

This week on Capitol Hill is another light one in terms of hearings focusing on topics related to technology and innovation. Although the House of Representatives is in session all week after the Columbus Day holiday, there are no hearings scheduled for the week as of Sunday,  and the House is about to enter a few weeks’ worth of district work periods. In the Senate, the Commerce Committee convenes a hearing to look at recent consumer data privacy laws passed in Europe and California, and the Banking Committee explores the potential of blockchain and cryptocurrencies in the national financial system.

Capitol Hill Roundup

This week in Capitol Hill hearings, it will be a relatively light week all around, and particularly so for those who focus on intellectual property, technology and innovation. Indeed, there are few hearings on tap for the week that might be of interest. Nevertheless, financial services innovation, health care cost reductions will be discussed in the Senate on Tuesday.

Infringe at Will Culture Takes Hold as America’s Patent System Erodes

Perhaps when the Senate Banking Committee convenes to consider the nomination of Wall Street attorney Jay Clayton as the new head of the Securities and Exchange Commission they should ask about efficient infringement and the infringe at will culture. What is your position, Mr. Clayton, on the legal obligation of a public company to shareholders? Should publicly traded companies inform shareholders that patent assets are worthless, or at least worth less, given the legal and regulatory climate in America? Should publicly traded companies systematically infringe and ignore all patent rights? Should publicly traded companies be using billions in shareholder monies to aggressively collect patent assets while they are simultaneously using millions to lobby against the viability of patents? What exactly do shareholders have a right to know?